Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia

European Journal of Neurology

Volumn 6, Issue 4, 1999, Pages 431-435

  Isoe Wada, Kenji ^a   Maeda, Masanobu ^a   Yong, Ji ^a   Adachi, Yoshiki ^a   Harada, Hideaki ^b   Urakami, Katsuya ^a   Nakashima, Kenji ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b NONE

Author keywords

Alzheimer's disease; Estrogen receptor gene; Genetic risk factor; Parkinson's disease; Polymorphism

Indexed keywords

ESTROGEN RECEPTOR;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0032802798     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1999.640431.x     Document Type: Article

References (30)

1. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders, 4th edition. Washington, DC: American Psychiatric Association.
2. Arai H, Muramatsu T, Higuchi S, Sasaki H, Trojanowski JQ (1994). Apolipoprotein E gene in Parkinson's disease with or without dementia. Lancet 344:889.
3. Costa P, Checkoway H, Levy D, Smith-Weller T, Franklin GM, Swanson PD, Costa LG (1997). Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genet 74:154-156.
4. Dulzen DE, McDermott JL, Liu B (1996). Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release. J Neurochem 66:658-666.
5. Fahn S, Cohen G (1992). The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 32:804-812.
6. Gibb WR (1989). Dementia and Parkinson's disease. Br J Psychiatry 154:596-614.
7. Gomez-Mancilla B, Bedard PJ (1992). Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTP-treated monkeys. Neurosci Lett 135:129-132.
8. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, et al. (1975). Cerebral blood flow in dementia. Arch Neurol 32:632-637.
9. Hosokawa T, Yamada Y, Isagoda A, Nakamura R (1994). Psychometric equivalence of the Hasegawa Dementia Scale - revised with the Mini-Mental State Examination in stroke patients. Percept Mot Skills 79:664-666.
10. Isoe K, Ji Y, Urakami K, Adachi Y, Nakashima K (1997). Genetic association of estrogen receptor gene polymorphisms with Alzheimer's disease. Alzheimer's Res 3:195-197.
11. Jellinger KA (1997). Morphological substrates of dementia in parkinsonism. A critical update. J Neural Transm Suppl 51:57-82.
12. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, et al. (1997). A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48:1517-1521
13. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H (1996). Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11:306-311
14. Koller WC, Glatt SL, Hubble JP, Paolo A, Troster AI, Handler MS, et al.(1995). Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol 37:242-245.
15. Lopez OL, Wisnieski SR, Becker JT, Boller F, DeKosky ST (1997). Extrapyramidal signs in patients with probable Alzheimer disease. Arch Neurol 54:969-975.
16. Marder K, Maestre G, Cote L, Mejia H, Alfaro B, Halim A, et al. (1994). The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology 44:1330-1331.
17. Marder K, Tang MX, Alfaro B, Mejia BH, Cote L, Jacob D, et al. (1998). Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology 50:1141-1143.
18. Mattila PM, Koskela T, Roytta M, Lehtimaki T, Pirttila TA, Ilveskoski E, et al. (1998). Apolipoprotein E epsilon4 allele frequency is increased in Parkinson's disease only with co-existing Alzheimer pathology. Acta Neuropathol (Berl) 96:417-420.
19. Mayeux R, Chen J, Mirabello E, Marder K, Bell K, Dooneief G, et al. (1990). An estimate of the incidence of dementia in idiopathic Parkinson's disease. Neurology 40:1513-1517.
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:934-944.
21. Nanko S, Ueki A, Hattori M (1996). No association between Parkinson's disease and monoamine oxidase A and B gene polymorphisms. Neurosci Lett 204:125-127.
22. Perl DP, Olanow CW, Calne D (1998). Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration? Ann Neurol 44(suppl 1):S19-S31
23. Rinne JO, Rummukainen J, Paljarvi L, Rinne UK (1989). Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 26:47-50.
24. Sandyk R (1989). Estrogens and the pathophysiology of Parkinson's disease. Int J Neurosci 45:119-122.
25. Session DR, Pearlstone MM, Jewelewicz R, Kelly AC (1994). Estrogens and Parkinson's disease. Med Hypotheses 42:280-282.
26. Smith CA, Gough AC, Leigh PN, Summers BA, Harding AE, Maraganore DM, et al. (1992). Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 339:375-1377.
27. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, et al. (1996). Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432.
28. Wakabayashi K, Kakita A, Hayashi S, Okuizumi K, Onodera O, Tanaka H, et al. (1998). Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease. Acta Neuropathol (Berl) 95:450-445
29. Yamamoto M, Kondo I, Ogawa N, Asanuma M, Yamashita Y, Mizuno Y (1997). Genetic association between susceptibility to Parkinson's disease and alpha1-antichymotrypsin polymorphism. Brain Res 759:153-155.
30. Zareparsi S, Kaye J, Camicioli R, Grimslid H, Oken B, Litt M, et al. (1997). Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes. Ann Neurol 42:655-658.